| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 19.821 | 48.152 | 21.133 | 34.784 | 20.830 | 22.538 | 23.006 | 19.861 | 58.766 |
| Total Income - EUR | - | 19.821 | 48.152 | 21.133 | 34.874 | 21.098 | 22.538 | 23.006 | 19.861 | 58.766 |
| Total Expenses - EUR | - | 186 | 127 | 126 | 139 | 161 | 187 | 198 | 130 | 79 |
| Gross Profit/Loss - EUR | - | 19.634 | 48.026 | 21.007 | 34.735 | 20.938 | 22.351 | 22.808 | 19.731 | 58.687 |
| Net Profit/Loss - EUR | - | 19.039 | 46.581 | 20.373 | 33.689 | 20.362 | 21.689 | 22.132 | 16.637 | 49.485 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Nopharma Vet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 17.101 | 46.891 | 20.483 | 33.766 | 20.467 | 21.861 | 22.350 | 17.721 | 54.001 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 1.573 | 522 | 0 | 0 | 17.795 | 17.735 | 12.114 | 27.463 |
| Cash | - | 17.101 | 45.318 | 19.961 | 33.766 | 20.466 | 4.066 | 4.615 | 5.607 | 26.538 |
| Shareholders Funds | - | 19.084 | 46.634 | 20.424 | 33.739 | 20.412 | 21.737 | 22.181 | 16.685 | 49.533 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | -1.983 | 257 | 59 | 27 | 55 | 124 | 169 | 1.035 | 4.468 |
| Income in Advance | - | -2.409 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Nopharma Vet Srl